Memo Therapeutics AG Appoints Paul Carter as Chairperson

PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and commercial preparations of AntiBKV Extensive public and private market

GlobeNewswireJul 8 07:00 ET

Improved Revenues Required Before Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Find Their Feet

You may think that with a price-to-sales (or "P/S") ratio of 2.4x Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is definitely a stock worth checking out, seeing as almost half of all the Biotechs compa

Simply Wall StJun 27 08:50 ET

Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Friday.Shares of Asana, Inc. (NYSE:ASAN) rose sharply during Friday's session after the company announced a $150 million sh

BenzingaJun 21 10:45 ET

Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer

Ironwood Pharmaceuticals (IRWD) said in a regulatory filing on Thursday that it has appointed Chief Financial Officer Sravan Emany to the additional role of chief operating officer, effective immediat

MT NewswiresJun 21 03:28 ET

Ironwood Pharmaceuticals CFO Emany Adds COO Role

By Paul Ziobro Ironwood Pharmaceuticals said Chief Financial Officer Sravan Emany will take on the added role of chief operating officer, effective immediately. Emany, 46, has served as the company'

WSJJun 20 16:52 ET

Express News | Ironwood Pharmaceuticals Appoints Sravan K. Emany As Senior Vice President, Chief Operating Officer, And Chief Financial Officer; Emany Previously Served As Senior Vice President, CFO Since December 2021

BenzingaJun 20 16:13 ET